Cosmos Health Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Greg Siokas
Chief executive officer
US$2.9m
Total compensation
CEO salary percentage | 37.5% |
CEO tenure | 9yrs |
CEO ownership | 20.2% |
Management average tenure | 4.3yrs |
Board average tenure | 4.5yrs |
Recent management updates
Recent updates
Market Might Still Lack Some Conviction On Cosmos Health Inc. (NASDAQ:COSM) Even After 31% Share Price Boost
Jan 18Positive Sentiment Still Eludes Cosmos Health Inc. (NASDAQ:COSM) Following 26% Share Price Slump
Aug 16Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch
Feb 23Cosmos Holdings intends to acquire telemedicine platform ZipDoctor
Sep 28Cosmos Holdings reports Q2 results
Aug 22Cosmos changes name to Cosmos Healthto
Jul 29Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically
Jul 20Cosmos Holdings to acquire bone health product portfolio from LIFE NLB
Jul 06CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$34m |
Jun 30 2024 | n/a | n/a | -US$29m |
Mar 31 2024 | n/a | n/a | -US$27m |
Dec 31 2023 | US$3m | US$1m | -US$26m |
Sep 30 2023 | n/a | n/a | -US$43m |
Jun 30 2023 | n/a | n/a | -US$42m |
Mar 31 2023 | n/a | n/a | -US$59m |
Dec 31 2022 | US$600k | n/a | -US$64m |
Compensation vs Market: Greg's total compensation ($USD2.88M) is above average for companies of similar size in the US market ($USD638.68K).
Compensation vs Earnings: Greg's compensation has increased whilst the company is unprofitable.
CEO
Greg Siokas (59 yo)
9yrs
Tenure
US$2,880,000
Compensation
Mr. Grigorios Siokas, also known as Greg, has been the Chairman and Chief Executive Officer of Cosmos Health Inc. (formerly known as Cosmos Holdings Inc.) since February 26, 2016 and served as its Presiden...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 9yrs | US$2.88m | 20.25% $ 3.0m | |
Chief Financial Officer | 4.3yrs | US$435.48k | 3.46% $ 513.2k | |
Chief Operating Officer | 2yrs | US$49.58k | 0.21% $ 31.8k | |
Secretary & Independent Director | 11.1yrs | US$23.76k | 0.095% $ 14.1k | |
Head of Oncology | less than a year | no data | no data |
4.3yrs
Average Tenure
57yo
Average Age
Experienced Management: COSM's management team is considered experienced (4.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 9yrs | US$2.88m | 20.25% $ 3.0m | |
Secretary & Independent Director | 11.1yrs | US$23.76k | 0.095% $ 14.1k | |
Independent Director & Member of Advisory Board | 2.2yrs | US$21.26k | 0.095% $ 14.1k | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | 6.3yrs | no data | no data | |
Independent Director | 2.8yrs | US$95.04k | 0.19% $ 28.2k | |
Independent Director | 8.3yrs | US$38.26k | 0.095% $ 14.1k | |
Member of Advisory Board | 2.6yrs | no data | no data | |
Director | 1.4yrs | US$83.40k | 0.14% $ 21.2k | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data |
4.5yrs
Average Tenure
59yo
Average Age
Experienced Board: COSM's board of directors are considered experienced (4.5 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/06 13:43 |
End of Day Share Price | 2025/02/06 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cosmos Health Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Howard Halpern | Taglich Brothers, Inc. |